When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OPNT - Opiant nabs second tranche of BARDA contract for nasal nalmefene
Opiant Pharmaceuticals Inc.
U.S. Health and Human Services unit BARDA has awarded the second tranche of its contract with Opiant Pharmaceuticals (NASDAQ:OPNT), valued at ~$2.4M, to accelerate the development of nasal nalmefene for the potential treatment of opioid overdose.
More news on: Opiant Pharmaceuticals, Inc., Healthcare stocks news,